Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has ...

NEMLUVIO is the first authorized monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling ...

More than 31 million Americans are living with eczema/ atopic dermatitis (AD), a chronic inflammatory skin condition that extends far beyond visible symptoms to disrupt sleep, mental health, and daily ...

J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action ...

Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...

Eczema can cause patches of angry, itchy skin on your face—but there are ways to find relief. Medically reviewed by Katlein Franca, MD A red face often means a person is either super embarrassed or ...

Perioral dermatitis is a skin condition characterized by a rash around the mouth. It is one type of dermatitis, which is a general term for skin irritation. In the word “perioral,” “peri” means ...

Seborrheic dermatitis is a common skin disease that causes an itchy rash with flaky scales. It causes redness on light skin and light patches on darker skin. It’s also called dandruff, cradle cap, ...

Seborrheic dermatitis is positively associated with a range of epithelial barrier diseases, including dermatologic, respiratory, gastrointestinal, and ocular diseases.

And the most recent article came out of JAMA in 2024, and they found that for every 1 g increase in urinary sodium, you ...

Contact dermatitis is a rash that crops up on your skin when you touch or have a reaction to a certain substance. It’s red, itchy, and uncomfortable, but it’s not life-threatening. The rash could be ...

Continued strong growth of ZORYVE® (roflumilast) in 2026 with full-year net product sales guidance of $455–$470 millionAdvancement of ZORYVE ...